TrueWealth LLC’s Gilead Sciences GILD Stock Holding History

TrueWealth LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$1.19M	Buy	15,522 +197	+1%	+$15.1K	0.5%	35
2020 Q1	$1.15M	Sell	15,325 -1,563	-9%	-$108K	0.56%	36
2019 Q4	$1.1M	Buy	16,888 +16,585	+5,474%	+$1.08M	0.44%	34
2019 Q3	$19K	Sell	303 -18	-6%	-$1.18K	0.01%	378
2019 Q2	$22K	Sell	321 -111	-26%	-$7.3K	0.01%	357
2019 Q1	$28K	Sell	432 -332	-43%	-$22.1K	0.01%	328
2018 Q4	$48K	Hold	764	–	–	0.02%	258
2018 Q3	$59K	Buy	764 +3	+0.4%	+$227	0.03%	250
2018 Q2	$54K	Buy	761 +266	+54%	+$18.8K	0.03%	257
2018 Q1	$37K	Sell	495 -704	-59%	-$56K	0.02%	289
2017 Q4	$86K	Buy	+1,199	New	+$91.1K	0.04%	226

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

TrueWealth LLC's GILD Position: Q2 2020 in Review

TrueWealth LLC increased its Gilead Sciences (GILD) stake by 1.3% in Q2 2020, buying an estimated $15.1K and bringing the position to 15,522 shares worth $1.19M. The position accounts for 0.5% of the portfolio, ranked #35.

TrueWealth LLC first reported a position in GILD in Q4 2017 and has held it in 11 quarters since. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

TrueWealth LLC held 15,522 shares of Gilead Sciences worth $1.19M as of Q2 2020.
TrueWealth LLC bought 197 Gilead Sciences shares in Q2 2020, an estimated $15.1K.
Gilead Sciences made up 0.5% of TrueWealth LLC's portfolio in Q2 2020, its #35 holding.
TrueWealth LLC first reported a position in Gilead Sciences in Q4 2017 and has held it in 11 quarters since.
1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.